Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cingulate Inc.CING · Entity 6983 | EVP and CFO | July 16, 2026 | July 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cingulate Inc.
Report date July 16, 2026 · Filed July 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.43 · Expires 2036-07-16 | Direct | 40,200 |
Reported balance
After 2026-07-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-16 · Grant · Acquired 40,200 · Balance 40,200 F1: The option vests as follows: 25% on March 31, 2027 and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date. |
| Stock Option (right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.43 · Expires 2036-07-16 | Direct | 19,800 |
Reported balance
After 2026-07-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-16 · Grant · Acquired 19,800 · Balance 19,800 F1: The option vests as follows: 25% on March 31, 2027 and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date. F2: Vested option only becomes exercisable if the Issuer's NDA for CTx-1301 is approved by the FDA during 2027. F3: If the Issuer's NDA for CTx-1301 is not approved by the FDA during 2027, the option, including any vested portion, shall terminate. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests as follows: 25% on March 31, 2027 and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date.
F2: Vested option only becomes exercisable if the Issuer's NDA for CTx-1301 is approved by the FDA during 2027.
F3: If the Issuer's NDA for CTx-1301 is not approved by the FDA during 2027, the option, including any vested portion, shall terminate.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 16, 2026 Filed Jul 20, 2026 23:29 UTC | Cingulate Inc. CING · Entity 6983 | GrantStock Option (right to Buy) · Derivative | 19,800 | $0.00 Strike: $4.43 | $0.00 |
DisclosureSEC source: 0001493152-26-033963 · ownership.xml · derivative · entry 2 Callahan Jennifer L. · CIK 0001883523 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,800 Underlying: Common Stock · 19,800 shares Expires 2036-07-16 F1 · derivative.exercise_date: The option vests as follows: 25% on March 31, 2027 and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date. F2 · derivative.exercise_date: Vested option only becomes exercisable if the Issuer's NDA for CTx-1301 is approved by the FDA during 2027. F3 · derivative.expiration_date: If the Issuer's NDA for CTx-1301 is not approved by the FDA during 2027, the option, including any vested portion, shall terminate. Read SEC document |
| July 16, 2026 Filed Jul 20, 2026 23:29 UTC | Cingulate Inc. CING · Entity 6983 | GrantStock Option (right to Buy) · Derivative | 40,200 | $0.00 Strike: $4.43 | $0.00 |
DisclosureSEC source: 0001493152-26-033963 · ownership.xml · derivative · entry 1 Callahan Jennifer L. · CIK 0001883523 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,200 Underlying: Common Stock · 40,200 shares Expires 2036-07-16 F1 · derivative.exercise_date: The option vests as follows: 25% on March 31, 2027 and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date. Read SEC document |
| March 09, 2026 Filed Mar 12, 2026 00:13 UTC | Cingulate Inc. CING · Entity 6983 | Tax withholdingCommon Stock | 6,427 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-009720 · ownership.xml · nonDerivative · entry 2 Callahan Jennifer L. · CIK 0001883523 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,961 F2 · security: Shares otherwise issuable were withheld to satisfy the Reporting Person's tax obligations on the grant described in footnote 1 above. Read SEC document |
| March 09, 2026 Filed Mar 12, 2026 00:13 UTC | Cingulate Inc. CING · Entity 6983 | GrantCommon Stock | 15,329 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-009720 · ownership.xml · nonDerivative · entry 1 Callahan Jennifer L. · CIK 0001883523 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,388 F1 · security: Shares of common stock were granted pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended, for a portion of the Reporting Person's 2025 bonus. Read SEC document |
| February 06, 2026 Filed Feb 11, 2026 00:00 UTC | Cingulate Inc. CING · Entity 6983 | PurchaseWarrant to Purchase Common Stock · Derivative | 3,891 | $0.10 Strike: $5.04 | $389.10 |
DisclosureSEC source: 0001493152-26-006026 · ownership.xml · derivative · entry 2 Callahan Jennifer L. · CIK 0001883523 · SVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,891 Underlying: Common Stock · 3,891 shares Expires not disclosed F1 · date: Common stock and warrants were acquired in the Issuer's private placement disclosed in the Current Report on Form 8-K filed with the SEC on January 28, 2026. F2 · derivative.exercise_date: The warrant is exercisable upon the Issuer obtaining stockholder approval of the private placement, as required by the Nasdaq rules. The expiration date of the warrant is 36 months after the exercise date. F2 · derivative.expiration_date: The warrant is exercisable upon the Issuer obtaining stockholder approval of the private placement, as required by the Nasdaq rules. The expiration date of the warrant is 36 months after the exercise date. Read SEC document |
| February 06, 2026 Filed Feb 11, 2026 00:00 UTC | Cingulate Inc. CING · Entity 6983 | PurchaseCommon Stock | 4,864 | $5.04 | $24,514.56 |
DisclosureSEC source: 0001493152-26-006026 · ownership.xml · nonDerivative · entry 1 Callahan Jennifer L. · CIK 0001883523 · SVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,059 F1 · date: Common stock and warrants were acquired in the Issuer's private placement disclosed in the Current Report on Form 8-K filed with the SEC on January 28, 2026. Read SEC document |
| July 07, 2025 Filed Jul 9, 2025 22:00 UTC | Cingulate Inc. CING · Entity 6983 | GrantStock Option (right to Buy) · Derivative | 64,500 | $0.00 Strike: $4.42 | $0.00 |
DisclosureSEC source: 0001641172-25-018477 · ownership.xml · derivative · entry 1 Callahan Jennifer L. · CIK 0001883523 · SVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,500 Underlying: Common Stock · 64,500 shares Expires 2035-07-07 F1 · derivative.exercise_date: The option vests as follows: 25% on the one-year anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 23:00 UTC | Cingulate Inc. CING · Entity 6983 | GrantStock Option (right to Buy) · Derivative | 21,140 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0001493152-25-007761 · ownership.xml · derivative · entry 1 Callahan Jennifer L. · CIK 0001883523 · SVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,140 Underlying: Common Stock · 21,140 shares Expires 2035-02-18 F1 · derivative.exercise_date: The option vests as follows: 25% on the one-year anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date. Read SEC document |
| January 17, 2025 Filed Jan 23, 2025 00:00 UTC | Cingulate Inc. CING · Entity 6983 | GrantStock Option (right to Buy) · Derivative | 11,539 | $0.00 Strike: $4.76 | $0.00 |
DisclosureSEC source: 0001493152-25-003292 · ownership.xml · derivative · entry 1 Callahan Jennifer L. · CIK 0001883523 · SVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,539 Underlying: Common Stock · 11,539 shares Expires 2035-01-17 F1 · date: The option was granted for a portion of Ms. Callahan's 2024 bonus. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 23:59 UTC | Cingulate Inc. CING · Entity 6983 | GrantStock Option (right to Buy) · Derivative | 94,986 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0001493152-24-023768 · ownership.xml · derivative · entry 1 Callahan Jennifer L. · CIK 0001883523 · SVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,986 Underlying: Common Stock · 94,986 shares Expires 2034-03-04 F1 · date: The stock option grant was approved by Cingulate Inc.'s board of directors on March 4, 2024, subject to stockholder approval of Amendment No.1 to the Cingulate Inc. 2021 Omnibus Equity Incentive Plan (the "Amendment"). Cingulate's stockholders approved the Amendment on June 11, 2024. F2 · derivative.exercise_date: The option vests as follows: 50% on the six-month anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 30-month period following the initial vesting date. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 23:00 UTC | Cingulate Inc. CING · Entity 6983 | GrantStock Option (right to Buy) · Derivative | 25,014 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0001493152-24-009087 · ownership.xml · derivative · entry 1 Callahan Jennifer L. · CIK 0001883523 · SVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,014 Underlying: Common Stock · 25,014 shares Expires 2034-03-04 F1 · derivative.exercise_date: The option vests as follows: 50% on the six-month anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 30-month period following the initial vesting date. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 22:00 UTC | Cingulate Inc. CING · Entity 6983 | PurchaseCommon Stock | 5,000 | $0.67 | $3,348.50 |
DisclosureSEC source: 0001493152-23-032961 · ownership.xml · nonDerivative · entry 1 Callahan Jennifer L. · CIK 0001883523 · Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,508 Read SEC document |
| May 15, 2023 Filed May 16, 2023 22:00 UTC | Cingulate Inc. CING · Entity 6983 | PurchaseCommon Stock | 2,000 | $1.01 | $2,020.00 |
DisclosureSEC source: 0001493152-23-017842 · ownership.xml · nonDerivative · entry 2 Callahan Jennifer L. · CIK 0001883523 · Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,508 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.0097 to $1.01 per share, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein. Read SEC document |
| May 12, 2023 Filed May 16, 2023 22:00 UTC | Cingulate Inc. CING · Entity 6983 | PurchaseWarrant to Purchase Common Stock · Derivative | 1,030 | $0.11 Strike: $6.00 | $112.79 |
DisclosureSEC source: 0001493152-23-017842 · ownership.xml · derivative · entry 3 Callahan Jennifer L. · CIK 0001883523 · Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,530 Underlying: Common Stock · 1,030 shares Expires 2026-12-10 F2 · price: The price reported in Column 4 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.1076 to $0.11 per warrant, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants purchased at each separate price within the ranges set forth herein. Read SEC document |
| May 12, 2023 Filed May 16, 2023 22:00 UTC | Cingulate Inc. CING · Entity 6983 | PurchaseCommon Stock | 4,000 | $1.08 | $4,320.00 |
DisclosureSEC source: 0001493152-23-017842 · ownership.xml · nonDerivative · entry 1 Callahan Jennifer L. · CIK 0001883523 · Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,508 Read SEC document |
| February 28, 2023 Filed Mar 9, 2023 02:02 UTC | Cingulate Inc. CING · Entity 6983 | GrantStock Option (right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0001493152-23-007042 · ownership.xml · derivative · entry 1 Callahan Jennifer L. · CIK 0001883523 · Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-02-28 F1 · derivative.exercise_date: The option vests as follows: 25% on the one-year anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date. Read SEC document |
| December 14, 2022 Filed Dec 15, 2022 23:00 UTC | Cingulate Inc. CING · Entity 6983 | PurchaseCommon Stock | 7,548 | $0.99 | $7,467.99 |
DisclosureSEC source: 0001493152-22-035631 · ownership.xml · nonDerivative · entry 1 Callahan Jennifer L. · CIK 0001883523 · Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,508 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.94 to $1.00 per share, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein. Read SEC document |
| November 29, 2022 Filed Nov 30, 2022 22:00 UTC | Cingulate Inc. CING · Entity 6983 | PurchaseCommon Stock | 1,530 | $0.98 | $1,499.40 |
DisclosureSEC source: 0001493152-22-034042 · ownership.xml · nonDerivative · entry 2 Callahan Jennifer L. · CIK 0001883523 · Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,960 Read SEC document |
| November 28, 2022 Filed Nov 30, 2022 22:00 UTC | Cingulate Inc. CING · Entity 6983 | PurchaseCommon Stock | 3,487 | $0.98 | $3,416.56 |
DisclosureSEC source: 0001493152-22-034042 · ownership.xml · nonDerivative · entry 1 Callahan Jennifer L. · CIK 0001883523 · Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,430 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9798 to $0.98 per share, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein. Read SEC document |
| September 08, 2022 Filed Sep 8, 2022 22:07 UTC | Cingulate Inc. CING · Entity 6983 | PurchaseCommon Stock | 3,500 | $1.50 | $5,249.65 |
DisclosureSEC source: 0001493152-22-025404 · ownership.xml · nonDerivative · entry 1 Callahan Jennifer L. · CIK 0001883523 · Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,943 Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 21:25 UTC | Cingulate Inc. CING · Entity 6983 | PurchaseWarrant to Purchase Common Stock · Derivative | 16,879 | $0.22 Strike: $6.00 | $3,696.50 |
DisclosureSEC source: 0001493152-22-007284 · ownership.xml · derivative · entry 2 Callahan Jennifer L. · CIK 0001883523 · Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 16,879 shares Expires 2026-12-10 F1 · price: The price reported in Column 8 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.2151 to $0.22 per warrant, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants purchased at each separate price within the ranges set forth herein. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 21:25 UTC | Cingulate Inc. CING · Entity 6983 | PurchaseCommon Stock | 1,900 | $1.39 | $2,641.00 |
DisclosureSEC source: 0001493152-22-007284 · ownership.xml · nonDerivative · entry 1 Callahan Jennifer L. · CIK 0001883523 · Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,443 Read SEC document |
| March 15, 2022 Filed Mar 22, 2024 22:00 UTC | Cingulate Inc. CING · Entity 6983 | PurchaseWarrant to Purchase Common Stock · Derivative | 1,500 | $0.30 Strike: $120.00 | $451.05 |
DisclosureSEC source: 0001493152-24-011034 · ownership.xml · derivative · entry 2 Callahan Jennifer L. · CIK 0001883523 · SVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,030 Underlying: Common Stock · 75 shares Expires 2026-12-10 F1 · derivative.exercise_price: The number of shares and price reflect the 1-for-20 reverse stock split of the Issuer's issued and outstanding shares of common stock, which became effective on November 30, 2023. F3 · price: The price reported in Column 8 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.2999 to $0.3094 per warrant, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants purchased at each separate price within the ranges set forth herein. F1 · derivative.underlying_shares: The number of shares and price reflect the 1-for-20 reverse stock split of the Issuer's issued and outstanding shares of common stock, which became effective on November 30, 2023. F2 · balance_after: Total number of securities includes purchases reflected on Forms 4 filed subsequent to the purchases this Form 4 covers. Read SEC document |
| March 15, 2022 Filed Mar 22, 2024 22:00 UTC | Cingulate Inc. CING · Entity 6983 | PurchaseCommon Stock | 55 | $27.10 | $1,490.50 |
DisclosureSEC source: 0001493152-24-011034 · ownership.xml · nonDerivative · entry 1 Callahan Jennifer L. · CIK 0001883523 · SVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,333 F1 · shares: The number of shares and price reflect the 1-for-20 reverse stock split of the Issuer's issued and outstanding shares of common stock, which became effective on November 30, 2023. F1 · price: The number of shares and price reflect the 1-for-20 reverse stock split of the Issuer's issued and outstanding shares of common stock, which became effective on November 30, 2023. F1 · balance_after: The number of shares and price reflect the 1-for-20 reverse stock split of the Issuer's issued and outstanding shares of common stock, which became effective on November 30, 2023. F2 · balance_after: Total number of securities includes purchases reflected on Forms 4 filed subsequent to the purchases this Form 4 covers. Read SEC document |
| March 14, 2022 Filed Mar 17, 2022 00:00 UTC | Cingulate Inc. CING · Entity 6983 | PurchaseWarrant to Purchase Common Stock · Derivative | 1,621 | $0.40 Strike: $6.00 | $652.29 |
DisclosureSEC source: 0001493152-22-007046 · ownership.xml · derivative · entry 2 Callahan Jennifer L. · CIK 0001883523 · Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,621 Underlying: Common Stock · 1,621 shares Expires 2026-12-10 F2 · price: The price reported in Column 4 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.3099 to $0.4612 per warrant, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants purchased at each separate price within the ranges set forth herein. Read SEC document |
| March 14, 2022 Filed Mar 17, 2022 00:00 UTC | Cingulate Inc. CING · Entity 6983 | PurchaseCommon Stock | 12,000 | $1.46 | $17,493.60 |
DisclosureSEC source: 0001493152-22-007046 · ownership.xml · nonDerivative · entry 1 Callahan Jennifer L. · CIK 0001883523 · Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,543 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.44 to $1.48 per share, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 23:01 UTC | Cingulate Inc. CING · Entity 6983 | GrantStock Option (right to Buy) · Derivative | 10,000 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001493152-22-005774 · ownership.xml · derivative · entry 1 Callahan Jennifer L. · CIK 0001883523 · Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-02-25 F1 · derivative.exercise_date: The option vests as follows: 25% on the one-year anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 23:00 UTC | Cingulate Inc. CING · Entity 6983 | GrantStock Option (right to Buy) · Derivative | 22,459 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001493152-21-031005 · ownership.xml · derivative · entry 1 Callahan Jennifer L. · CIK 0001883523 · Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,459 Underlying: Common Stock · 22,459 shares Expires 2031-12-07 F1 · derivative.exercise_date: The option vests in four equal annual installments commencing on December 7, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.